Detection and Characterization of Drug-Resistant Organisms
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: closed (30 October 2022) | Viewed by 65642
Special Issue Editors
Interests: vaccine and drug development; pharmacology; drug resistance; host–pathogen interactions; biochemistry; molecular biology; microbiology
Special Issues, Collections and Topics in MDPI journals
Interests: malaria vaccine; innate immunology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In this era, several nations are facing the scourge of more than one pathogen. This situation has raised significant awareness, and more efforts are being given to find the treatment of infectious diseases, primarily caused by bacteria, parasites, and viruses. Several drugs and derivatives are being discovered that have a range of effects against pathogens. Despite reasonable success in disease prognosis and in resolving the issue, development of resistant forms of these pathogens has been a setback. There are multiple levels of resistance, namely: multi-drug resistant (MDR), extremely drug resistant (XDR), and, in some cases, totally drug resistant (TDR) strains of the pathogens have also evolved. These include bacterial diseases, such as tuberculosis, pneumonia, and gonorrhea; viral diseases, such as HIV; and parasitic diseases, such as Lyme disease and malaria. Besides resistance, pathogens also exhibit persistence or tolerance to the drugs, without actually mutating. This Special Issue, entitled “Detection and Characterization of Antibiotic Resistant Organisms”, focuses on the concepts of resistance, persistence, and tolerance in human pathogens and their detection, characterization, and treatment. This Special Issue emphasizes the escalating problem of drug-resistance in pathogens, and supplements the existing literature on several diseases.
In this Issue, the discussion is open to a range of topics, including the following:
- Manuscripts can be focused on the reasons behind the development of drug-resistance: (a) variations at a pathogen level, including mutations, molecular alterations, gene expression, post-translational modifications, evolution, dormancy, and persistence; (b) host level variations, such as level of infection, immune response, microbiome, compliance, and side-effects; and (c) drug designing, substrates of efflux-pumps, pharmacokinetics, activation, chemical properties, drug-targets, etc.
- Detection of drug resistant organisms: the detection of drug resistant strains of the pathogens has been a major obstacle for all diseases. The diagnosis of a disease and its treatment with appropriate drugs can only be achieved once the pathogen’s sensitivity level has been defined. With this background, we will discuss the small-scale and high-throughput screening of the patient samples, which will help in detection.
- Unfortunately, a large number of infections now exhibit resistance to one or more drugs, and need to be treated after careful diagnosis. The extent of the problem can be understood from the emergence of infections that are untreatable with the currently available regimen. In view of this, there will be discussions on the characterization of drug resistant organisms and strategies to combat and resolve the drug resistance. This can extend from the prevention to the treatment of infections.
- Other topics that are not mentioned here but are still relevant to the broad topic of this Special Issue are also welcome.
Dr. Andaleeb Sajid
Dr. Gunjan Arora
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotics
- drugs
- resistance
- bacterial pathogens
- viruses
- vector-borne diseases
- persistence
- drug targets
- genetic mutations
- MDR
- XDR
- high-throughput screening
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.